Subarachnoid hemorrage –eso guidelines for management
Upcoming SlideShare
Loading in...5
×
 

Subarachnoid hemorrage –eso guidelines for management

on

  • 204 views

neurocritical care

neurocritical care

Statistics

Views

Total Views
204
Views on SlideShare
204
Embed Views
0

Actions

Likes
1
Downloads
6
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Subarachnoid hemorrage –eso guidelines for management Subarachnoid hemorrage –eso guidelines for management Presentation Transcript

  • Dr.Abdulgafoor.M.T ;MD ICU ,ALKHOR HOSPITAL
  • Incidence:9 per 100000(Japan &Finland 15-17) Mortality:60% within 6 months with conservative treatment One third die from rebleeding within 6 months 1.6 times higher in females Median age of onset 50-60 years 90%of aneurysms less than 10mm and 90% in ACA circulation EPIDEMIOLOGY
  • Statement on Definition  Ruptured intracranial aneurysm’ (RIA)  Unruptured intracranial aneurysm’ (UIA); asymptomatic’ or ‘symptomatic’  A symptomatic UIA usually causes brain nerve palsy or rarely can cause arterial embolism  Asymptomatic UIAs are usually found incidentally DEFINITIONS BY ESO (EUROPEAN STROKE ORGANIZATION)
  • Hunt& Hess grading 1.Asymptomatic, mild headache, slight nuchal rigidity 2.Moderate to severe headache, nuchal rigidity, no neurologic deficit other than cranial nerve palsy 3.Drowsiness / confusion, mild focal neurologic deficit 4.Stupor, moderate-severe hemiparesis 5.Coma, decerebrate posturing CLINICAL APPEARANCE &GRADING
  • gra de GCS Focal neurological deficit 1 15 Absent 2 13–14 Absent 3 13–14 Present 4 7–12 Present or absent 5 <7 Present or absent WFNS(WORLD FEDERATION OF NEURO SURGEONS) GRADING
  • Grade(1) GCS 15 Grade(2) GCS 11 to 14; Grade(3) GCS 8 to10 Grade (4) GCS 4 to 7; Grade (5) GCS 3. PAASH(PROGNOSIS ON ADMISSION OF ANEURYSMAL SUBARACHNOID HEMORRHAGE) GRADING Better correlated with outcome than WFNS
  • FISCHER GRADING Grade Appearance of hemorrhage 1 None evident 2 Less than 1 mm thick 3 More than 1 mm thick 4 Diffuse or none with intraventricular hemorrhage or parenchymal extension
  • Modified by Claassen and coworkers, reflecting the additive risk from SAH size and accompanying Intraventricular hemorrhage 0 – none 1 - minimal SAH w/o IVH 2 - minimal SAH with IVH 3 - thick SAH w/o IVH 4 - thick SAH with IVH
  • Recommendation • It is recommended that the initial assessment of SAH patients,and therefore the grading of the clinical condition, is done by means of a scale based on the GCS • The PAASH scale performs slightly better than the WFNS scale, which has been used more often (Grade3 Level C) RECOMMENDATION-GRADING
  • Patient factors:Age,Hypertension,High systolic BP,Alcohol consumption,smoking (for delayed cerebral ischemia) Aneurysm factors:Size and site of Aneurysm Disease associated:Rebleeding,Delayed cerebral ischemia,Hydrocephalus Treatment associated:Aneurysm clipping or coiling Complications due to prolonged bed rest. PREDICTORS OF OUTCOME
  • STATEMENT-RISK FACTORS
  • 10% in first degree relatives 5-8% in first or second degree Family history of Aneurysm in 10% Polycystic kidney disease is associated RECOMMENDATION-SCREENING
  • CT is useful in the early period .Afterward redistribution and resorption of blood occurs.After 5 days of bleed CT can detect only 85% and after 2 weeks 30% MRI with flair technology comparable to CT in the early period and superior in the late stage Water clear CSF during LP rules out SAH within 2-3 weeks Gold standard :Cerebral panangiography.(sensitivity 0.77-0.97 &Specificity0.87-1) DIAGNOSIS
  • RECOMMENDATION-DIAGNOSIS
  • – Intensive continuous observation at least until occlusion of the aneurysm – Continuous ECG monitoring Hourly  GCS,  focal deficits,  blood pressure and  temperature at least every hour MONITORING
  • Statement on Physical Management  Avoid situations that increase intracranial pressure, The patient should be kept in bed Antiemetic drugs, laxatives and analgesics should be considered before occlusion of the aneurysm (GCP) STATEMENT-TREATMENT
  •  Recommendation for Blood Glucose Management Hyperglycemia over 10 mmol/l should be treated (GCP)  Blood pressure Management Stop antihypertensive medication that the patient was using Do not treat hypertension unless it is extreme; BP limits to be set on an individual basis,depending on age , pre-SAH BP and cardiac history; systolic blood pressure should be kept below 180 mm Hg, only until coiling or clipping of ruptured aneurysm, RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT  Sizure at onset 7%  10% Develop sizure in first few weeks  Convulsive status epilepticus in 0.2%  Nonconvulsive status epilepticus in comatose patients 8%  Continuous EEG –no improvement in outcome  In one RCT outcome worst in 65% who received prophylactic antiepileptics Vs 35% in those didn’t receive .
  • RECOMMENDATION-TREATMENT
  • First few hours 15% rebleeds 24 hrs to 4 weeks:35-40% rebleeds After 4 weeks: 3% per year Case fatality rate day 1:25-30% 1 week :40-45% First Month:55-60% First Year:65% Five Year:65-70% 12%Die before reaching hospital OUTCOME
  • Included only aneurysms which can be clipped or coiled. 90%were good grades MCA aneurysms underrepresented Absolute risk reduction of death and disability after 1 year 6.9%(23.7% Vs 30.6%) Reduction in relative 5 year mortality in favour of coiling Retreatment more in coiling(17.4% Vs 3.8%) For young patients below 40 years clipping better ISAT STUDY
  • RECOMMENDATIONS-INTERVENTION
  • RECOMMENDATIONS-TREATMENT
  • HYDROCEPHALUS
  • RECOMMENDATION
  • RECOMMENDATION-TREATMENT
  • RECOMMENDATION-TREATMENT Triple H therapy: can cause increased cerebral oedema, haemorrhagic transformation in areas of infarction , reversible leucencephalopathy , myocardial infarction and congestive heart failure.
  • SAH WITHOUT ANEURYSM
  • Asymptomatic incidental aneurysm Symptomatic aneurysm Aneurysms in SAH patients(multiple aneurysm) UNRUPTURED ANEURYSM
  • RECOMMENDATION-UNRUPTURED INTRACRANIAL ANEURYSMS